Champions Oncology Stock Forecast

Buy candidate since Jul 13, 2026

The Champions Oncology stock price fell by -0.172% on the last day (Monday, 13th Jul 2026) from $5.82 to $5.81. During the last trading day the stock fluctuated 6.28% from a day low at $5.74 to a day high of $6.10. The price has fallen in 6 of the last 10 days and is down by -12.37% for this period. Volume has increased on the last day by 887 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 thousand shares were bought and sold for approximately $19.46 thousand.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.77 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.08% during the next 3 months and, with a 90% probability hold a price between $5.89 and $7.06 at the end of this 3-month period.

CSBR Signals & Forecast

The Champions Oncology stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.86 and $6.04. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Champions Oncology gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued. Some positive signals were issued as well, and these may have some influence on the near short-term development. A buy signal was issued from a pivot bottom point on Thursday, July 02, 2026, and so far it has risen 0.87%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Champions Oncology stock

Champions Oncology finds support from accumulated volume at $5.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.361 between high and low, or 6.28%. For the last week, the stock has had daily average volatility of 6.80%.

Our recommended stop-loss: $5.52 (-4.96%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (CSBR) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Champions Oncology to open at $5.88, and during the day (based on 14 day Average True Range), to move between $5.61 and $6.01, which gives a possible trading interval of +/-$0.400 (+/-7.13%) up or down from last closing price. If Champions Oncology takes out the full calculated possible swing range there will be an estimated 7.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.80 (0.17%) than the resistance at $5.85 (0.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Champions Oncology stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.168 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $5.88 ( 1.27%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk